Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical advances in targeting epigenetics for cancer therapy
Shengrui Feng, Daniel D. De Carvalho
FEBS Journal (2021) Vol. 289, Iss. 5, pp. 1214-1239
Open Access | Times Cited: 70

Showing 26-50 of 70 citing articles:

Epigenetic drivers of metalloproteinases and metastasis
Marco Seehawer, Kornélia Polyák
Trends in Cell Biology (2025)
Closed Access
Navigating the future of gastric cancer treatment: a review on the impact of antibody-drug conjugates
Qian-Qing Yin, Yanlong Zhang, Xueqing Xie, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy
İsa Taş, Reinhilde Jacobs, Juliane Albrecht, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Targeted chemo-photodynamic therapy toward esophageal cancer by GSH-sensitive theranostic nanoplatform
Guodong Ren, ZiCheng Wang, Yafei Tian, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113506-113506
Open Access | Times Cited: 16
Clinical advances in epigenetic therapies for lymphoma
Allison Rosenthal, Javier Muñoz, José C. Villasboas
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approaches
Srinjan Bhattacharya, Rahul Kumar Mahato, Satwinder Singh, et al.
Life Sciences (2023) Vol. 332, pp. 122110-122110
Open Access | Times Cited: 10
Therapeutic regulation of epigenetics in cancer treatment through drug delivery systems
Boyu Su, Shangkuo Li, Shuo Geng, et al.
Nano Today (2024) Vol. 56, pp. 102251-102251
Closed Access | Times Cited: 3
Pan-Cancer Analysis of Human Kinome Gene Expression and Promoter DNA Methylation Identifies Dark Kinase Biomarkers in Multiple Cancers
Siddesh Southekal, Nitish K. Mishra, Chittibabu Guda
Cancers (2021) Vol. 13, Iss. 6, pp. 1189-1189
Open Access | Times Cited: 23
Epigenetic tumor heterogeneity in the era of single-cell profiling with nanopore sequencing
Yohannis Wondwosen Ahmed, Berhan Ababaw Alemu, Sisay Addisu Bekele, et al.
Clinical Epigenetics (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Discovery of potent DNMT1 inhibitors against sickle cell disease using structural-based virtual screening, MM-GBSA and molecular dynamics simulation-based approaches
Ala Chandu, Renuka Parshuram Joshi, Pragya Gupta, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 1, pp. 261-273
Open Access | Times Cited: 8
METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma
Kesong Shi, Rula Sa, Le Dou, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Cancer epigenetics: promises and pitfalls for cancer therapy
Eleni Skourti, Paraminder Dhillon
FEBS Journal (2022) Vol. 289, Iss. 5, pp. 1156-1159
Closed Access | Times Cited: 13
Tackling drug resistance in ovarian cancer with epigenetic targeted drugs
Lin Zhao, Hongjie Guo, Xi Chen, et al.
European Journal of Pharmacology (2022) Vol. 927, pp. 175071-175071
Closed Access | Times Cited: 13
Targeting Histone Epigenetic Modifications and DNA Damage Responses in Synthetic Lethality Strategies in Cancer?
Pedro A. Lazo
Cancers (2022) Vol. 14, Iss. 16, pp. 4050-4050
Open Access | Times Cited: 13
It Takes Two to Tango: The Interplay between Prostate Cancer and Its Microenvironment from an Epigenetic Perspective
Anniek Zaalberg, Elisabeth Pottendorfer, Wilbert Zwart, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 294-294
Open Access | Times Cited: 2
HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells
Flavia Trionfetti, Tonino Alonzi, Giulio Bontempi, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
The impact of epigenetic modifications on allogeneic hematopoietic stem cell transplantation
Yiouli P. Ktena, Margarita Dionysiou, Lukasz P. Gondek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
2D Nano Covalent Organic Frameworks – A Porous Polymeric Promising Material Exploring New Prospects of Drug Delivery in Cancer Therapeutics
Akash M. Chandran, N Abhirami, S. Sudhina, et al.
ChemistrySelect (2023) Vol. 8, Iss. 24
Closed Access | Times Cited: 4
Long non-coding RNA SOX21-AS1: A potential tumor oncogene in human cancers
Zhengyu Lu, Jin Xu, Binhao Cao, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154774-154774
Closed Access | Times Cited: 4
Epigenetic contribution to cancer
Songhua Quan, Hao Huang
International review of cell and molecular biology (2024), pp. 1-25
Closed Access | Times Cited: 1
Screening of DNMT3A inhibitors from phytochemicals using molecular docking and molecular dynamics simulation for their anti-cancer potential
Satbir Kour, Dhamodharan Prabhu, Indrani Biswas, et al.
Molecular Simulation (2024) Vol. 50, Iss. 14, pp. 1001-1018
Closed Access | Times Cited: 1
Epigenetic Mechanisms Are Involved in the Oncogenic Properties of ZNF518B in Colorectal Cancer
Francisco Gimeno-Valiente, Ángela L. Riffo‐Campos, Luís Torres, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1433-1433
Open Access | Times Cited: 8
A Short Overview of Resistance to Approved Histone Deacetylase Inhibitors
Fabian Fischer, Leandro A. Alves Avelar
Future Medicinal Chemistry (2021) Vol. 13, Iss. 14, pp. 1153-1155
Closed Access | Times Cited: 8
PCDH17 gene promoter methylation status in a cohort of Egyptian women with epithelial ovarian cancer
Sherif Mohamed Elsharkawi, Dalal Elkaffash, Pacint Moez, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth
Suresh Chava, Suresh Bugide, Parmanand Malvi, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104752-104752
Open Access | Times Cited: 4

Scroll to top